Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

TCT 550: Combined Use of Off-Label Intravascular Lithotripsy and Brachytherapy for the Treatment of Recurrent Intracoronary Stent Restenosis

Presentation TCT 2020

TCT 550: Combined Use of Off-Label Intravascular Lithotripsy and Brachytherapy for the Treatment of Recurrent Intracoronary Stent Restenosis

Presenter: Ilias Nikolakopoulos

October 14, 2020

TCT 592: Recurrent In-Stent Restenosis - Exhausted Treatment Options?

Presentation TCT 2020

TCT 592: Recurrent In-Stent Restenosis - Exhausted Treatment Options?

Presenter: Mohammed Osheiba

October 14, 2020

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

Presentation TCT 2020

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

Presenter: Charan Yerasi

October 14, 2020

TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion

Presentation TCT 2020

TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion

Presenter: Sandeep Basavarajaiah

October 14, 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

Case 1 – Retrograde approach by septal branches (to treat occlusive ISR)

Presentation JIM 2020

Case 1 – Retrograde approach by septal branches (to treat occlusive ISR)

Presenter: Mauro Carlino

February 12, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.